Table 6.
Investigation |
Outpatients: (n = 53) |
Inpatients: (n = 111) |
---|---|---|
WES | 13 (24%) | 12 (11%) |
Microarray | 8 (15%) | 10 (9%) |
MRI | 2 (4%) | 39 (35%) |
Metabolic screening | 1 (2%) | 8 (7%) |
Genetic panel | 3 (7%) | 6 (5%) |
Targeted gene | 1 (2%) | 1 (1%) |
Negative WES | 1 (2%) | 4 (4%) |
Pending results or no other testing sent | 24 (45%) | 31 (28%) |